Boston Scientific (NYSE:BSX) shares are trading lower on Tuesday after the company announced a global voluntary recall and discontinuation of its LOTUS Edge aortic valve system due to complexities with the delivery system.
Boston Scientific produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, interventional oncology, and treatment of incontinence.
Boston Scientific shares were trading down 10.20% at $34.16 on Tuesday during the time of publication. The stock has a 52-week high of $46.62 and a 52-week low of $24.10.